Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
AARTI DRUGS 551.70 1.03% 549.25 0.66%
 More Info 
AJANTA PHARMA 1,196.80 0.71% 1,195.90 0.65%
 More Info 
ALEMBIC PHARMA 589.10 -1.18% 590.45 -0.91%
 More Info 
BIOCON LTD 592.10 -0.80% 591.30 -1.06%
 More Info 
CADILA HEALTHCARE 356.80 4.99% 357.25 5.01%
 More Info 
CIPLA 648.15 0.12% 646.90 -0.22%
 More Info 
DIVIS LABORATORIES 1,173.00 0.85% 1,174.75 0.89%
 More Info 
GLENMARK PHARMA 600.15 2.91% 600.15 2.90%
 More Info 
INDOCO REMEDIES 198.45 1.07% 198.90 0.30%
 More Info 
IPCA LABS 731.40 -0.18% 733.25 -0.14%
 More Info 
J.B.CHEMICALS 307.65 -1.00% 308.15 -0.64%
 More Info 
LUPIN LTD 879.35 3.53% 881.25 3.71%
 More Info 
NATCO PHARMA 752.50 0.05% 754.40 0.33%
 More Info 
NIFTY 50 Not Listed 11,470.75 0.75%
 More Info 
ORCHID PHARMA LTD 7.41 -2.88% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 231.85 3.16% 230.60 2.08%
 More Info 
PIRAMAL ENTERPRISES 2,706.35 -0.17% 2,703.20 -0.30%
 More Info 
S&P BSE SENSEX 37,947.88 0.75% Not Listed
 More Info 
STRIDES SHASUN LTD 449.35 4.09% 449.10 4.01%
 More Info 
SUN PHARMA 623.30 0.60% 623.50 0.61%
 More Info 
TORRENT PHARMA 1,766.70 3.98% 1,765.90 3.87%
 More Info 
WOCKHARDT LTD. 624.60 1.01% 625.35 1.11%
 More Info 

BSE prices: August 17, 2018  (Close)    NSE prices: August 17, 2018  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 9,693.9 (up 1.0%). The index is up 8.6% over the last 30 days. And over the last 1 year, it has gained 10.2%.

Within the Indian Pharma sector, the top gainers were CADILA HEALTHCARE (up 5.0%) and STRIDES SHASUN LTD (up 4.1%). On the other hand, ORCHID PHARMA LTD (down 2.9%) and ALEMBIC PHARMA (down 1.2%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 11,470.8 (up 0.8%).

Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1% (Quarterly Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

For the quarter ended June 2018, SUN PHARMA has posted a net profit of Rs 11 bn (up 446.1% YoY). Sales on the other hand came in at Rs 72 bn (up 16.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Aug 17, 2018 (Close)